Search
The Newsletter
The Principals
Reports
Conferences
Databases
Custom Research
Contact Us
Home
 

Online Report Subscribers, Click Here
Pricing and Ordering Information

 Download A246 Datasheet

U.S. Markets for Interventional Peripheral Vascular Disease Management Products and Technologies
Report #A246 - September 2009
240 Pages - 65 Exhibits - 17 Company Profiles

Peripheral vascular disease (PVD) refers to those conditions that affect the vessels carrying blood to and from the extremities as well as the tissues and organs of the abdominal and pelvic cavities. The most commonly diagnosed form of PVD is plaque-related peripheral artery disease; other types of PVD include aneurysm, chronic venous insufficiency, deep-vein thrombosis, and pulmonary embolism.

In 2008, approximately 3.0 million interventional procedures for the diagnosis and treatment of PVD were performed in the United States (U.S.), generating an estimated $1.18 billion in corresponding product sales. The number of diagnostic and therapeutic interventions for PVD management is expected to increase at a compound annual rate of 3.1% during the forecast period covered by this report, reaching nearly 3.5 million in the year 2013. Sales of products to perform these interventional procedures are projected to increase at a compound annual rate of 9.2% during the forecast period covered by this report, reaching an estimated $1.83 billion in the year 2013.

This dynamic, new report from Medtech Insight includes analyses of products, current and emerging markets, competitors, and opportunities for suppliers of interventional devices for the diagnosis and treatment of PVD in the U.S.

Covered topics in this report include angiography devices; catheter-directed thrombolysis products; chronic total occlusion crossing systems; drug-eluting balloon systems; endovascular cryotherapy products; endovascular embolization products; intravascular ultrasound systems; mechanical atherectomy systems; mechanical and pharmacomechanical thrombectomy products; noninvasive peripheral vascular disease treatments; peripheral transluminal angioplasty devices; surgical/endoscopic peripheral vascular disease treatments; and vena cava filters.

Ordering Information

Title

 Report# Publication
Date		 List Price

U.S. Markets for Interventional Peripheral Vascular Disease Management Products and Technologies

A246

September 2009

$4,750
Order Online:
Single User only (Please call for corporate subscription pricing)		 PDF Only

Print versions of Reports are available upon request for an additional fee.

Methodology

Reports are produced exclusively by Medtech Insight, through extensive primary and secondary research among the clinicians, researchers, and competitors in the marketplace, and draw upon the industry expertise of a network of industry insiders. Medtech Insight exhaustively corroborates the data as a baseline for completing forward-looking analysis and providing insight into product, technology and market evolution.

 

TABLE OF CONTENTS

 

Executive Summary

i.    Interventional Peripheral Vascular Disease Diagnostic Products Market

a.   Angiography

b.   Intravascular Ultrasound

ii.    Interventional Peripheral Vascular Disease Treatment Products Market

a.   Percutaneous Transluminal Angioplasty

b.   Catheter-Directed Thrombolysis

c.    Chronic Total Occlusion Crossing

d.   Mechanical Atherectomy

e.   Endovascular Embolization

f.    Thrombectomy

g.   Vena Cava Filter Placement

h.   Endovascular Cryotherapy

i.    Drug-Eluting Balloon Angioplasty

iii.   Methodology

 

Exhibit ES-1:    Interventional Peripheral Vascular Disease Management, Combined Procedure Volumes Forecast, 2008-2013

Exhibit ES-2:    Interventional Peripheral Vascular Disease Management Products, Combined Market Forecast, 2008-2013

Exhibit ES-3:    Interventional Peripheral Vascular Disease Management Products, Combined Market Forecast, by Segment 2008-2013

Exhibit ES-4:    Angiography Devices for Peripheral Vascular Disease Diagnostics, Market Forecast, 2008-2013

Exhibit ES-5:    Intravascular Ultrasound Catheters, Market Forecast, 2008-2013

Exhibit ES-6:    Percutaneous Transluminal Angioplasty Devices, Market Forecast, 2008-2013

Exhibit ES-7:    Catheter-Directed Thrombolysis Systems, Market Forecast, 2008-2013

Exhibit ES-8:    Powered Chronic Total Occlusion Crossing Systems,  Market Forecast, 2008-2013

 

Exhibit ES-9:    Mechanical Atherectomy Systems, Market Forecast, 2008-2013

Exhibit ES-10:  Endovascular Embolization Products, Market Forecast, 2008-2013

Exhibit ES-11:  Thrombectomy Systems,Market Forecast, 2008-2013

Exhibit ES-12:  Vena Cava Filter Systems, Market Forecast, 2008-2013

Exhibit ES-13:  Endovascular Cryotherapy Systems, Market Forecast,  2008-2013

Exhibit ES-14:  Drug Eluting Balloon Angioplasty Systems, Market Forecast, 2008-2013

 

1. Peripheral Vascular Disease Overview

1.1 Anatomy and Physiology of the Circulatory System

1.2 Types of Peripheral Vascular Disease

1.2.1 Peripheral Artery Disease

1.2.1.1 Etiology

1.2.1.2 Epidemiology

1.2.2 Aneurysm

1.2.2.1 Etiology

1.2.2.2 Epidemiology

1.2.3 Deep Vein Thrombosis and Pulmonary Embolism

1.2.3.1 Etiology

1.2.3.2 Epidemiology

1.2.4 Chronic Venous Insufficiency

1.2.4.1 Etiology

1.2.4.2 Epidemiology

 

Exhibit 1-1:      2009, Peripheral Artery Disease, Facts and Figures

Exhibit 1-2:      2009, Aortic Aneurysm, Facts and Figures

Exhibit 1-3:      2009, Deep Vein Thrombosis, Facts and Figures

Exhibit 1-4:      Classification of Chronic Venous Insufficiency

Exhibit 1-5:      2009, Chronic Venous Insufficiency, Facts and Figures

 

2. Interventional Peripheral Vascular Disease Diagnostic Products Market

2.1 Noninvasive Peripheral Vascular Disease Diagnostics

2.1.1 Ankle/Brachial Index

2.1.2 Exercise Tolerance Testing

2.1.3 Imaging Methods

2.1.3.1 Computed Tomography

2.1.3.2 Magnetic Resonance Imaging

2.1.3.3 Thermography

2.1.3.4 Ultrasound Imaging

2.1.4 Photoplethysmography and Air Plethysmography

2.2 Interventional Peripheral Vascular Disease Diagnostics, Market Analysis

2.2.1 Angiography

2.2.1.1 Types

2.2.1.1.1 Peripheral Arterial Angiography

2.2.1.1.2 Peripheral Venous Angiography

2.2.1.2 Procedures/Technologies

2.2.1.3 Products

2.2.1.4 Market Forecast

2.2.1.5 Competitors

2.2.2 Intravascular Ultrasound

2.2.2.1 Procedures/Technologies

2.2.2.2 Products

2.2.2.3 Market Forecast

2.2.2.4 Competitors

 

Exhibit 2-1:      Interventional Peripheral Vascular Disease Diagnosis, Combined Procedure Volumes Forecast, 2008-2013

Exhibit 2-2:      Interventional Peripheral Vascular Disease Diagnostic Products, Combined Market Forecast, 2008-2013

Exhibit 2-3:      Peripheral Angiography, Procedure Volumes Forecast, 2008-2013

Exhibit 2-4:      2009, Selected Angiography Catheters

 

Exhibit 2-5:      2009, Selected Diagnostic Guidewires

Exhibit 2-6:      2009, Selected Introducers/Sheaths

Exhibit 2-7:      Angiography Devices for Peripheral Vascular Disease Diagnostics, Market Forecast, 2008-2013

Exhibit 2-8:      2008, Market for Angiography Devices for Peripheral Vascular Disease Diagnostics, Share by Supplier

Exhibit 2-9:      Intravascular Ultrasound, Procedure Volumes Forecast, 2008-2013

Exhibit 2-10:    2009, Selected Intravascular Ultrasound Catheters

Exhibit 2-11:    Intravascular Ultrasound Catheters, Market Forecast, 2008-2013

Exhibit 2-12:    2008, Intravascular Ultrasound Catheters Market, Share by Supplier

 

3. Interventional Peripheral Vascular Disease Treatment Products Market

3.1 Noninvasive Peripheral Vascular Disease Treatments

3.1.1 Lifestyle Changes

3.1.1.1 Exercise Therapy

3.1.1.2 Diet Modification

3.1.1.3 Smoking Cessation

3.1.1.4 Compression Therapy

3.1.2 Drug Therapy

3.1.2.1 Anticoagulants and Antiplatelet Drugs

3.1.2.2 Dyslipidemia Management Drugs

3.2 Surgical/Endoscopic Peripheral Vascular Disease Treatments

3.2.1 Femoropopliteal Bypass Graft Surgery

3.2.2 Thromboendarterectomy

3.2.3 Chronic Venous Insufficiency and Venous Ulceration Treatments

3.2.3.1 Deep Vein Reconstruction

3.2.3.2 Open Subfascial Perforator Surgery

3.2.3.3 Skin Grafting

3.2.3.4 Subfascial Endoscopic Perforator Surgery

3.2.3.5 Superficial Vein Stripping

 

3.3 Interventional Peripheral Vascular Disease Treatments, Market Analysis

3.3.1 Percutaneous Transluminal Angioplasty

3.3.1.1 Procedures/Technologies

3.3.1.2 Products

3.3.1.2.1 Balloon Catheters

3.3.1.2.2 Guiding Catheters

3.3.1.2.3 Guidewires

3.3.1.2.4 Introducers/Sheaths

3.3.1.2.5 Accessories

3.3.1.3 Market Forecast

3.3.1.4 Competitors

3.3.2 Catheter-Directed Thrombolysis

3.3.2.1 Procedures/Technologies

3.3.2.2 Products

3.3.2.3 Market Forecast

3.3.2.4 Competitors

3.3.3 Chronic Total Occlusion Crossing

3.3.3.1 Procedures/Technologies

3.3.3.2 Products

3.3.3.3 Market Forecast

3.3.3.4 Competitors

3.3.4 Mechanical Atherectomy

3.3.4.1 Procedures/Technologies

3.3.4.2 Products

3.3.4.3 Market Forecast

3.3.4.4 Competitors

3.3.5 Endovascular Embolization

3.3.5.1 Procedures/Technologies

3.3.5.2 Products

3.3.5.3 Market Forecast

3.3.5.4 Competitors

3.3.6 Thrombectomy

3.3.6.1 Procedures/Technologies

3.3.6.2 Products

3.3.6.3 Market Forecast

3.3.6.4 Competitors

3.3.7 Vena Cava Filter Placement

3.3.7.1 Procedures/Technologies

3.3.7.2 Products

3.3.7.3 Market Forecast

3.3.7.4 Competitors

3.3.8 Other/Emerging

3.3.8.1 Endovascular Cryotherapy

3.3.8.1.1 Procedures/Technologies

3.3.8.1.2 Products

3.3.8.1.3 Market Forecast

3.3.8.2 Drug-Eluting Balloon Angioplasty

3.3.8.2.1 Procedures/Technologies

3.3.8.2.2 Products

3.3.8.2.3 Market Forecast

 

Exhibit 3-1:      Interventional Peripheral Vascular Disease Treatment, Combined Procedure Volumes Forecast, 2008-2013

Exhibit 3-2:      Interventional Peripheral Vascular Disease Treatment Products, Combined Market Forecast, 2008-2013

Exhibit 3-3:      Percutaneous Transluminal Angioplasty, Procedure Volumes Forecast, 2008-2013

Exhibit 3-4:      2009, Selected Percutaneous Transluminal Angioplasty Balloon Catheters

Exhibit 3-5:      Percutaneous Transluminal Angioplasty Devices, Market Forecast, 2008-2013

Exhibit 3-6:      2008, Percutaneous Transluminal Angioplasty Devices Market, Share by Supplier

Exhibit 3-7:      Catheter-Directed Thrombolysis, Procedure Volumes Forecast, 2008-2013

Exhibit 3-8:      2009, Selected Catheter-Directed Thrombolysis Systems

Exhibit 3-9:      Catheter-Directed Thrombolysis Systems, Market Forecast, 2008-2013

Exhibit 3-10:    2008, Catheter-Directed Thrombolysis Systems Market, Share by Supplier

Exhibit 3-11:    Powered Chronic Total Occlusion Crossing, Procedure Volumes Forecast, 2008-2013

Exhibit 3-12:    2009, Selected Powered Chronic Total Occlusion Crossing Systems

Exhibit 3-13:    Powered Chronic Total Occlusion Crossing Systems, Market Forecast, 2008-2013

Exhibit 3-14:    2008, Powered Chronic Total Occlusion Crossing Systems Market, Share by Supplier

Exhibit 3-15:    Mechanical Atherectomy, Procedure Volumes Forecast, 2008-2013

Exhibit 3-16:    2009, Selected Mechanical Atherectomy Systems

Exhibit 3-17:    Mechanical Atherectomy Systems, Market Forecast, 2008-2013

Exhibit 3-18:    2008, Mechanical Atherectomy Systems Market, Share by Supplier

Exhibit 3-19:    Endovascular Embolization, Procedure Volumes Forecast, 2008-2013

Exhibit 3-20:    2009, Selected Endovascular Embolization Products

Exhibit 3-21:    Endovascular Embolization Products, Market Forecast, 2008-2013

Exhibit 3-22:    2008, Endovascular Embolization Products Market, Share by Supplier

Exhibit 3-23:    Thrombectomy, Procedure Volumes Forecast, 2008-2013

Exhibit 3-24:    2009, Selected Thrombectomy Systems

Exhibit 3-25:    Thrombectomy Systems, Market Forecast, 2008-2013

Exhibit 3-26:    2008, Thrombectomy Systems Market, Share by Supplier

Exhibit 3-27:    Vena Cava Filter Placement, Procedure Volumes Forecast, 2008-2013

Exhibit 3-28:    2009, Selected Vena Cava Filter Systems

Exhibit 3-29:    Vena Cava Filter Systems, Market Forecast, 2008-2013

Exhibit 3-30:    2008, Vena Cava Filter Systems Market, Share by Supplier

Exhibit 3-31:    Endovascular Cryotherapy, Procedure Volumes Forecast,  2008-2013

Exhibit 3-32:    Endovascular Cryotherapy Systems,Market Forecast, 2008-2013

 

Exhibit 3-33:    Drug-Eluting Balloon Angioplasty, Procedure Volumes Forecast, 2008-2013

Exhibit 3-34:    Drug-Eluting Balloon Angioplasty Systems, Market Forecast, 2008-2013

4. COMPANY PROFILES

4.1       Abbott Laboratories

4.2       AngioDynamics, Inc.

4.3       Arrow International/Teleflex, Inc.

4.4       Bacchus Vascular/Covidien LTD

4.5       C.R. Bard, Inc.

4.6       BioSphere Medical, Inc.

4.7       Boston Scientific Corporation

4.8       B. Braun Melsungen AG

4.9       Cardiovascular Systems, Inc.

4.10     Cook Group

4.11     Cordis Corporation/Johnson & Johnson

4.12     ev3, Inc.

4.13     MEDRAD Interventional Possis/Bayer HealthCare/Bayer Group

4.14     Medtronic, Inc.

4.15     Spectranetics Corporation

4.16     Terumo Interventional Systems/Terumo Corporation

4.17     Volcano Corporation

 

appendix:     company listing

 

 

 

To order reports or obtain information about special pre-publication offers from within the U.S., contact sales@medtechinsight.com. From outside the U.S., contact internationalsales@medtechinsight.com. You can also call 1.949.453.0071 (or toll-free within the U.S. at 1.888.290.2225) or fax 1.949.453.0072.

 

The Newsletter | The Principals | Reports | Conferences | Physician Surveys | Consulting | Contact Us | Home